STRYKER CORP Deferred Tax Asset, Interest Carryforward
STRYKER CORP (SYK) had Deferred Tax Asset, Interest Carryforward of $56.00 million as of 2025-12-31, per its 10-K filed 2026-02-11.
Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Deferred Tax Assets, Net › Deferred Tax Assets, Net of Valuation Allowance › Deferred Tax Assets, Gross
us-gaap:DeferredTaxAssetInterestCarryforward · last filed 2026-02-11
- 2025-12-31: Deferred Tax Asset, Interest Carryforward $56.00M.
- 2024-12-31: Deferred Tax Asset, Interest Carryforward $52.00M.
- 2023-12-31: Deferred Tax Asset, Interest Carryforward $46.00M.
- 2022-12-31: Deferred Tax Asset, Interest Carryforward $135.00M.
| Period end | Deferred Tax Asset, Interest Carryforward |
|---|---|
| 2025-12-31 | $56.00M 10-K · filed 2026-02-11 |
| 2024-12-31 | $52.00M 10-K · filed 2026-02-11 |
| 2023-12-31 | $46.00M 10-K · filed 2025-02-12 |
| 2022-12-31 | $135.00M 10-K · filed 2024-02-14 |
| 2021-12-31 | $0.00 10-K · filed 2023-02-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| 3M CO (MMM) | United States | $86.404B | 27.87 |
| BOSTON SCIENTIFIC CORP (BSX) | United States | $64.781B | 17.29 |
| BECTON DICKINSON & CO (BDX) | United States | $48.834B | 43.79 |
| DEXCOM INC (DXCM) | United States | $33.004B | 25.42 |
| WEST PHARMACEUTICAL SERVICES INC (WST) | United States | $26.288B | 43.14 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |